Results 171 to 180 of about 6,725 (211)

Update on Ocular Myasthenia Gravis

Seminars in Neurology, 2019
AbstractMyasthenia gravis is an antibody-mediated autoimmune disorder of the post-synaptic neuromuscular junction resulting in fluctuating, fatigable weakness. Most patients first present with extraocular symptoms (diplopia and/or ptosis), and in 15% of cases symptoms will remain restricted to only the extraocular muscles (ocular myasthenia gravis [OMG]
Meabh, O'Hare, Christopher, Doughty
openaire   +2 more sources

Childhood ocular myasthenia gravis

Ophthalmology, 2003
To investigate the clinical manifestations and ocular findings in children with ocular myasthenia gravis (MG) that rarely have been reported in the literature.Retrospective, noncomparative case series.Twenty-four consecutive patients less than 15 years of age with ocular MG treated between June 1988 and July 2001.The medical records of 6 boys and 18 ...
Jong-Hyun, Kim, Jeong-Min, Hwang, Yong Seung, Hwang, Ki Joong, Kim, Jonghee, Chae   +4 more
openaire   +2 more sources

Treatment of Ocular Myasthenia Gravis

Current Treatment Options in Neurology, 2011
Myasthenia gravis (MG) is an autoimmune disorder that is characterized by variable weakness and fatigability. Often, MG presents with only ocular symptoms such as ptosis and diplopia. Treatment of ocular MG is aimed at relieving the symptoms of ptosis and diplopia, as well as preventing the development of generalized MG symptoms.
Scott R, Haines, Matthew J, Thurtell
openaire   +2 more sources

Pediatric Ocular Myasthenia Gravis

Current Treatment Options in Neurology, 2019
We present a review of current strategies in the treatment of pediatric ocular myasthenia gravis (OMG). A critical appraisal was performed of the current literature available on OMG and the treatment options available for all age populations. From this data, we present the evidence surrounding therapeutic options for pediatric OMG and discuss treatment
Kristen, Fisher, Veeral, Shah
openaire   +2 more sources

Myasthenia gravis: Antibodies to acetylcholine receptor in ocular myasthenia gravis

Journal of Neurology, 1981
To improve the sensitivity of the radioimmunoassay method for anti-AChR-antibody, large amounts of sera from patients with myasthenia gravis, and higher concentrations of antigens and rabbit anti-human-IgG-antiserum, were used. These procedures enabled measurement of the titre value of over 0.04 pmol/ml serum and this value revealed a sensitivity about
K, Oda, Y, Ito
openaire   +2 more sources

Ocular myasthenia gravis

Current Opinion in Ophthalmology, 1996
Ocular myasthenia gravis may mimic any pupil-spared, painless, nonproptotic ophthalmoplegia with or without ptosis. This review references recent papers regarding clinical features, diagnostic techniques, and treatment for ocular myasthenia gravis.
openaire   +2 more sources

Ocular myasthenia gravis

Current Opinion in Ophthalmology, 2018
Myasthenia gravis is an autoimmune disease that commonly affects the palpebral and extraocular muscles. Ocular myasthenia gravis (OMG) is a variant of the disease that is confined to the ocular muscles but frequently becomes generalized over time.
Elizabeth, Fortin, Dean M, Cestari, David H, Weinberg   +2 more
openaire   +2 more sources

Penicillamine-Induced Ocular Myasthenia Gravis

American Journal of Ophthalmology, 1985
Two patients with rheumatoid arthritis (two women, 58 and 62 years old) developed reversible penicillamine-induced ocular myasthenia gravis. Both had the HLA-DR1 antigen, unlike most patients with idiopathic myasthenia gravis who show HLA-DR3, suggesting that penicillamine-induced myasthenia gravis and its idiopathic counterpart occur in patients with ...
M, O'Keefe, K D, Morley, W M, Haining, A, Smith   +3 more
openaire   +2 more sources

Ocular Myasthenia Gravis

Archives of Neurology, 1997
In their discussion of the results of a retrospective chart review of 32 patients with ocular myasthenia gravis treated with prednisone for variable periods, Kupersmith and colleagues 1 neglected to mention the only controlled clinical trial of anything in myasthenia—namely, of corticotropin.
openaire   +1 more source

Ocular Myasthenia Gravis and Hashimoto's Thyroiditis

American Journal of Ophthalmology, 1975
Two patients had ocular myasthenia gravis coexistent with Hashimoto's thyroiditis. A 37-year-old woman presented with diplopia and displayed a head tremor and thyroid enlargement. Thyroid function tests showed an elevated thyroid stimulating hormone (TSH).
R H, Osher, J L, Smith
openaire   +2 more sources